ARTICLE
2 October 2021

Health Agencies' COVID Work To Persist In Event Of Shutdown

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Stacy Cline Amin spoke to Bloomberg Law about the U.S. Food and Drug Administration's (FDA) plans to continue working to combat the COVID-19 pandemic in the event of a government shutdown.
United States Food, Drugs, Healthcare, Life Sciences

Stacy Cline Amin spoke to Bloomberg Law about the U.S. Food and Drug Administration's (FDA) plans to continue working to combat the COVID-19 pandemic in the event of a government shutdown.

According to Stacy, agencies with public safety functions, like the FDA, must evaluate each activity they conduct to determine if it has a source of funding or falls into an exception for "emergency circumstances" that would allow it to continue that work during a shutdown.

Although there is a public health emergency declaration for the pandemic, it doesn't mean the "emergency circumstances" exception during a shutdown applies to all public health work, Stacy added. Agencies must evaluate each nonfunded activity to determine if stopping it would "imminently threaten human life or the protection of property."

Read the  full article (subscription required).

Originally published by Bloomberg Law

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More